The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...

The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn't impose any tariff on ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

The US president announced a 27 per cent reciprocal tariff on India, claiming the South Asian country imposes a 52 per cent ...

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...

Pharma stocks plummet as Trump threatens tariffs, impacting US-dependent companies and leading to market volatility.

Of the $91 billion worth of India’s exports to the US, nearly $20 billion are expected to come under some form of exemption ...

Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical ...

AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, to import ...